Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease

Takao Yasuhara, Tetsuro Shingo, Kenichiro Muraoka, Kazuki Kobayashi, Akira Takeuchi, Akimasa Yano, Yuan Wenji, Masahiro Kameda, Toshihiro Matsui, Yasuyuki Miyoshi, Isao Date

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Object. Glial cell line-derived neurotrophic factor (GDNF) has been shown to confer neuroprotective effects on dopaminergic neurons. The authors investigated the effects of GDNF on 6-hydroxydopamine (6-OHDA)-treated dopaminergic neurons in vitro and in vivo. Methods. First, the authors examined how 1, 10, or 100 ng/ml of GDNF, administered to cells 24 hours before, simultaneously with, or 2 or 4 hours after 6-OHDA was added, affected dopaminergic neurons. In a primary culture of E14 murine ventral mesencephalic neurons, earlier treatment with the higher dosage of GDNF suppressed 6-OHDA-induced loss of dopaminergic neurons better than later treatment. Next, the authors examined whether continuous infusion of GDNF at earlier time points would demonstrate a greater neuroprotective effect in a rat model of Parkinson disease (PD). They established a human GDNF-secreting cell line, called BHK-GDNF, and encapsulated the cells into hollow fibers. The encapsulated cells were unilaterally implanted into the striatum of adult rats 1 week before; simultaneously with; or 1, 2, or 4 weeks after 6-OHDA was given to induce lesions of the same striatum. With the earlier transplantation of a BHK-GDNF capsule, there was a significant reduction in the number of amphetamine-induced rotations displayed by the animals. Rats that had received earlier implantation of BHK-GDNF capsules displayed more tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta and a tendency for glial proliferation in the striatum. Conclusions. These neuroprotective effects may be related to glial proliferation and signaling via the GDNF receptor a1. The results of this study support a role for this grafting technique in the treatment of PD.

Original languageEnglish
Pages (from-to)80-89
Number of pages10
JournalJournal of Neurosurgery
Volume102
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Glial Cell Line-Derived Neurotrophic Factor
Neuroprotective Agents
Parkinson Disease
Transplantation
Oxidopamine
Dopaminergic Neurons
Neuroglia
Capsules
Glial Cell Line-Derived Neurotrophic Factor Receptors
Neurons
Tyrosine 3-Monooxygenase
Amphetamine
Cell Line

Keywords

  • Dopaminergic neuron
  • Encapsulation
  • Glial cell line-derived neurotrophic factor
  • Glial cell line-derived neurotrophic factor receptor-α1
  • Neuroprotection
  • Parkinson disease
  • Rat

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. / Yasuhara, Takao; Shingo, Tetsuro; Muraoka, Kenichiro; Kobayashi, Kazuki; Takeuchi, Akira; Yano, Akimasa; Wenji, Yuan; Kameda, Masahiro; Matsui, Toshihiro; Miyoshi, Yasuyuki; Date, Isao.

In: Journal of Neurosurgery, Vol. 102, No. 1, 01.2005, p. 80-89.

Research output: Contribution to journalArticle

Yasuhara, Takao ; Shingo, Tetsuro ; Muraoka, Kenichiro ; Kobayashi, Kazuki ; Takeuchi, Akira ; Yano, Akimasa ; Wenji, Yuan ; Kameda, Masahiro ; Matsui, Toshihiro ; Miyoshi, Yasuyuki ; Date, Isao. / Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. In: Journal of Neurosurgery. 2005 ; Vol. 102, No. 1. pp. 80-89.
@article{b77f70d855fb43ffbdda3c508dfb562a,
title = "Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease",
abstract = "Object. Glial cell line-derived neurotrophic factor (GDNF) has been shown to confer neuroprotective effects on dopaminergic neurons. The authors investigated the effects of GDNF on 6-hydroxydopamine (6-OHDA)-treated dopaminergic neurons in vitro and in vivo. Methods. First, the authors examined how 1, 10, or 100 ng/ml of GDNF, administered to cells 24 hours before, simultaneously with, or 2 or 4 hours after 6-OHDA was added, affected dopaminergic neurons. In a primary culture of E14 murine ventral mesencephalic neurons, earlier treatment with the higher dosage of GDNF suppressed 6-OHDA-induced loss of dopaminergic neurons better than later treatment. Next, the authors examined whether continuous infusion of GDNF at earlier time points would demonstrate a greater neuroprotective effect in a rat model of Parkinson disease (PD). They established a human GDNF-secreting cell line, called BHK-GDNF, and encapsulated the cells into hollow fibers. The encapsulated cells were unilaterally implanted into the striatum of adult rats 1 week before; simultaneously with; or 1, 2, or 4 weeks after 6-OHDA was given to induce lesions of the same striatum. With the earlier transplantation of a BHK-GDNF capsule, there was a significant reduction in the number of amphetamine-induced rotations displayed by the animals. Rats that had received earlier implantation of BHK-GDNF capsules displayed more tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta and a tendency for glial proliferation in the striatum. Conclusions. These neuroprotective effects may be related to glial proliferation and signaling via the GDNF receptor a1. The results of this study support a role for this grafting technique in the treatment of PD.",
keywords = "Dopaminergic neuron, Encapsulation, Glial cell line-derived neurotrophic factor, Glial cell line-derived neurotrophic factor receptor-α1, Neuroprotection, Parkinson disease, Rat",
author = "Takao Yasuhara and Tetsuro Shingo and Kenichiro Muraoka and Kazuki Kobayashi and Akira Takeuchi and Akimasa Yano and Yuan Wenji and Masahiro Kameda and Toshihiro Matsui and Yasuyuki Miyoshi and Isao Date",
year = "2005",
month = "1",
doi = "10.3171/jns.2005.102.1.0080",
language = "English",
volume = "102",
pages = "80--89",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

TY - JOUR

T1 - Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease

AU - Yasuhara, Takao

AU - Shingo, Tetsuro

AU - Muraoka, Kenichiro

AU - Kobayashi, Kazuki

AU - Takeuchi, Akira

AU - Yano, Akimasa

AU - Wenji, Yuan

AU - Kameda, Masahiro

AU - Matsui, Toshihiro

AU - Miyoshi, Yasuyuki

AU - Date, Isao

PY - 2005/1

Y1 - 2005/1

N2 - Object. Glial cell line-derived neurotrophic factor (GDNF) has been shown to confer neuroprotective effects on dopaminergic neurons. The authors investigated the effects of GDNF on 6-hydroxydopamine (6-OHDA)-treated dopaminergic neurons in vitro and in vivo. Methods. First, the authors examined how 1, 10, or 100 ng/ml of GDNF, administered to cells 24 hours before, simultaneously with, or 2 or 4 hours after 6-OHDA was added, affected dopaminergic neurons. In a primary culture of E14 murine ventral mesencephalic neurons, earlier treatment with the higher dosage of GDNF suppressed 6-OHDA-induced loss of dopaminergic neurons better than later treatment. Next, the authors examined whether continuous infusion of GDNF at earlier time points would demonstrate a greater neuroprotective effect in a rat model of Parkinson disease (PD). They established a human GDNF-secreting cell line, called BHK-GDNF, and encapsulated the cells into hollow fibers. The encapsulated cells were unilaterally implanted into the striatum of adult rats 1 week before; simultaneously with; or 1, 2, or 4 weeks after 6-OHDA was given to induce lesions of the same striatum. With the earlier transplantation of a BHK-GDNF capsule, there was a significant reduction in the number of amphetamine-induced rotations displayed by the animals. Rats that had received earlier implantation of BHK-GDNF capsules displayed more tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta and a tendency for glial proliferation in the striatum. Conclusions. These neuroprotective effects may be related to glial proliferation and signaling via the GDNF receptor a1. The results of this study support a role for this grafting technique in the treatment of PD.

AB - Object. Glial cell line-derived neurotrophic factor (GDNF) has been shown to confer neuroprotective effects on dopaminergic neurons. The authors investigated the effects of GDNF on 6-hydroxydopamine (6-OHDA)-treated dopaminergic neurons in vitro and in vivo. Methods. First, the authors examined how 1, 10, or 100 ng/ml of GDNF, administered to cells 24 hours before, simultaneously with, or 2 or 4 hours after 6-OHDA was added, affected dopaminergic neurons. In a primary culture of E14 murine ventral mesencephalic neurons, earlier treatment with the higher dosage of GDNF suppressed 6-OHDA-induced loss of dopaminergic neurons better than later treatment. Next, the authors examined whether continuous infusion of GDNF at earlier time points would demonstrate a greater neuroprotective effect in a rat model of Parkinson disease (PD). They established a human GDNF-secreting cell line, called BHK-GDNF, and encapsulated the cells into hollow fibers. The encapsulated cells were unilaterally implanted into the striatum of adult rats 1 week before; simultaneously with; or 1, 2, or 4 weeks after 6-OHDA was given to induce lesions of the same striatum. With the earlier transplantation of a BHK-GDNF capsule, there was a significant reduction in the number of amphetamine-induced rotations displayed by the animals. Rats that had received earlier implantation of BHK-GDNF capsules displayed more tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta and a tendency for glial proliferation in the striatum. Conclusions. These neuroprotective effects may be related to glial proliferation and signaling via the GDNF receptor a1. The results of this study support a role for this grafting technique in the treatment of PD.

KW - Dopaminergic neuron

KW - Encapsulation

KW - Glial cell line-derived neurotrophic factor

KW - Glial cell line-derived neurotrophic factor receptor-α1

KW - Neuroprotection

KW - Parkinson disease

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=13844280470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844280470&partnerID=8YFLogxK

U2 - 10.3171/jns.2005.102.1.0080

DO - 10.3171/jns.2005.102.1.0080

M3 - Article

VL - 102

SP - 80

EP - 89

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 1

ER -